stonks4u
Sign up free
BCLI logo

BCLI Brainstorm Cell Therapeutics Inc.

Other OTC · Biotechnology · Healthcare

$0.99
+0.17 (+21.32%)

Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to pr…

Market Cap: $10.92Mwww.brainstorm-cell.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 14Aug 14

Quote

Day Range
$0.80 – $1.00
52-Week Range
$0.46 – $1.69
Volume
$31.8K
Market Cap
$10.92M
50-Day Avg
$0.93
200-Day Avg
$0.74
Prev Close
$0.82
Open
$0.85

Valuation & Ratios

P/E Ratio
-0.50
EPS
$-1.11
P/B Ratio
-0.50
P/S Ratio
0.00
Debt/Equity
-0.02
Current Ratio
0.03
Dividend Yield
+0.0%
Gross Margin
+0.0%

Returns & Efficiency

Return on Equity
+100.1%
Return on Assets
-1441.5%
FCF Yield
-136.8%
EV/EBITDA
-0.54

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$0.00$-10.31M$-1.11
2024$0.00$11.62M$2.19
2023$0.00$-17.19M$-4.48
2022$0.00$-24.28M$-9.93
2021$0.00$-24.46M$-10.09

Social Signal Score

50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Mon, Nov 16(in 3 months)

Consensus estimate $-0.21 per share

4of 7 quarters beat consensus

Typical surprise +17.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Aug 14$-0.35 vs $-0.29miss
  • Fri, May 15$-0.19 vs $-0.36beat
  • Tue, Mar 31$-0.19 vs $-0.28beat
  • Fri, Nov 14$-0.91 vs $-0.35miss
  • Thu, Aug 14$-0.34 vs $-0.41beat
  • Thu, May 15$-0.45 vs $-0.97beat

Estimates and results for BCLI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

BCLIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsprnewswire.com·1d ago·Neutral

    …utics Announces Second Quarter 2026 Financial Results and Provides Corporate Update NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update. "We continue to advance and complete the preparations necessary to initiate the Phase 3b ENDURANCE study of NurOwn in ALS, supported…

    View source ↗